4edw
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab)== | ==Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab)== | ||
- | <StructureSection load='4edw' size='340' side='right' caption='[[4edw]], [[Resolution|resolution]] 2.48Å' scene=''> | + | <StructureSection load='4edw' size='340' side='right'caption='[[4edw]], [[Resolution|resolution]] 2.48Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4edw]] is a 3 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4edw]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EDW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4EDW FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4edw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4edw OCA], [https://pdbe.org/4edw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4edw RCSB], [https://www.ebi.ac.uk/pdbsum/4edw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4edw ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/NGF_HUMAN NGF_HUMAN]] Defects in NGF are the cause of hereditary sensory and autonomic neuropathy type 5 (HSAN5) [MIM:[https://omim.org/entry/608654 608654]]. The hereditary sensory and autonomic neuropathies are a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN5 patients manifest loss of pain perception and impaired temperature sensitivity, ulcers, and in some cases self-mutilation. The autonomic involvement is variable.<ref>PMID:14976160</ref> <ref>PMID:20978020</ref> <ref>PMID:22302274</ref> |
== Function == | == Function == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/NGF_HUMAN NGF_HUMAN]] Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. Extracellular ligand for the NTRK1 and NGFR receptors, activates cellular signaling cascades through those receptor tyrosine kinase to regulate neuronal proliferation, differentiation and survival. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 22: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 4edw" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4edw" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Nerve growth factor|Nerve growth factor]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Eigenbrot C]] |
- | [[Category: | + | [[Category: Ultsch M]] |
- | + | ||
- | + | ||
- | + |
Revision as of 07:06, 28 September 2022
Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab)
|